Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FRAT1 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of FRAT1 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FRAT1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of FRAT1 mRNA | CTD | PMID:20106945 and PMID:31614463 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of FRAT1 mRNA | CTD | PMID:16631469 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of FRAT1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [decitabine results in increased expression of FRAT1 mRNA] | CTD | PMID:15251184 | 2-hydroxypropanoic acid | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of FRAT1 mRNA | CTD | PMID:30851411 | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of FRAT1 mRNA | CTD | PMID:18648102 | 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Decitabine results in increased expression of FRAT1 mRNA] | CTD | PMID:15251184 | 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | Decitabine results in increased expression of FRAT1 mRNA | CTD | PMID:15251184 | afimoxifene | multiple interactions | ISO | FRAT1 (Homo sapiens) | 6480464 | afimoxifene inhibits the reaction [Estrogens results in decreased expression of FRAT1 mRNA] | CTD | PMID:21233418 | aflatoxin B1 | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of FRAT1 mRNA | CTD | PMID:27153756 | arsenous acid | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of FRAT1 mRNA | CTD | PMID:29633893 | atrazine | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of FRAT1 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of FRAT1 mRNA | CTD | PMID:22228805 and PMID:27195522 | benzo[a]pyrene | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of FRAT1 mRNA | CTD | PMID:32234424 | butanal | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of FRAT1 mRNA | CTD | PMID:26079696 | carbamazepine | affects expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of FRAT1 mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes and Carbon results in increased expression of FRAT1 mRNA | CTD | PMID:25620056 | cisplatin | multiple interactions | ISO | FRAT1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of FRAT1 mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | FRAT1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FRAT1 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | FRAT1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FRAT1 mRNA | CTD | PMID:20971185 | cyclosporin A | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of FRAT1 mRNA | CTD | PMID:20106945 more ... | diarsenic trioxide | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of FRAT1 mRNA | CTD | PMID:29633893 | dorsomorphin | multiple interactions | ISO | FRAT1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRAT1 mRNA | CTD | PMID:27188386 | elemental selenium | increases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Selenium results in increased expression of FRAT1 mRNA | CTD | PMID:19244175 | ethyl methanesulfonate | increases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of FRAT1 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FRAT1 mRNA | CTD | PMID:22206623 | gamma-hexachlorocyclohexane | increases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Hexachlorocyclohexane results in increased expression of FRAT1 mRNA | CTD | PMID:24356939 | iron dichloride | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of FRAT1 mRNA | CTD | PMID:35984750 | lipopolysaccharide | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of FRAT1 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | FRAT1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FRAT1 mRNA | CTD | PMID:35811015 | maneb | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of FRAT1 mRNA | CTD | PMID:36117858 | ochratoxin A | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | ochratoxin A metabolite results in decreased expression of FRAT1 mRNA and ochratoxin A results in decreased expression of FRAT1 mRNA | CTD | PMID:24356939 | paracetamol | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of FRAT1 mRNA | CTD | PMID:29067470 | paraquat | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of FRAT1 mRNA | CTD | PMID:36117858 | pentanal | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | pentanal results in decreased expression of FRAT1 mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FRAT1 mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of FRAT1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | FRAT1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRAT1 mRNA | CTD | PMID:27188386 | propanal | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of FRAT1 mRNA | CTD | PMID:26079696 | quercetin | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of FRAT1 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of FRAT1 mRNA | CTD | PMID:30851411 | rotenone | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of FRAT1 mRNA | CTD | PMID:29955902 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | FRAT1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FRAT1 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | FRAT1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRAT1 mRNA | CTD | PMID:27188386 | selenium atom | increases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Selenium results in increased expression of FRAT1 mRNA | CTD | PMID:19244175 | sirolimus | increases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Sirolimus results in increased expression of FRAT1 mRNA | CTD | PMID:24356939 | sunitinib | increases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of FRAT1 mRNA | CTD | PMID:31533062 | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of FRAT1 mRNA | CTD | PMID:33045310 | urethane | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Urethane results in decreased expression of FRAT1 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of FRAT1 mRNA | CTD | PMID:23179753 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FRAT1 mRNA | CTD | PMID:21427059 | valproic acid | decreases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of FRAT1 mRNA | CTD | PMID:29154799 | vitamin E | increases expression | ISO | FRAT1 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of FRAT1 mRNA | CTD | PMID:19244175 | |